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ABSTRACT
Opioid use disorder (OUD) is a type of substance use disorder characterized by repeated
use of opioid drugs. These drugs are known to be rapidly addictive with severe withdrawal
symptoms, making death due to overdose a rising concern. In this study, we took a closer look at
a specific population of women, all of whom had children and were incarcerated for crimes
related to opioid use. Our goal was to better understand the factors that would impact success
among this group seeking medication-assisted treatment for OUD. We developed a set of
questions focused on a variety of factors including stigma surrounding the disorder, influence of
the disorder on parenting, approaches and barriers to treatment, and potential motivation for
seeking treatment. We then virtually interviewed women participating in the Orange County
Corrections Medication for Opioid Use Disorder Program, specifically in the Methadone Clinic,
to better understand their experiences with OUD and methadone treatment. The goal of this
study is to give better insight into existing treatment options in order to suggest revisions to
current policies. By doing so, we hope to increase rates of recovery from OUD and to provide
better future outcomes.
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INTRODUCTION
The opioid epidemic has swept the United States and continues to grow, with the number
of deaths due to overdose steadily increasing. In 2019, there were 49,860 recorded deaths from
opioid-involved overdose (Overdose Death Rates). The influence that this has on families is
significant. In the United States alone, 7.5 million children live with someone who suffers from a
substance use disorder (Chopra & Marasa, 2017). Many treatment options exist in hopes to
combat this epidemic and diminish the negative effect that it can have on families.
This study focuses on the various elements that could influence success among
incarcerated mothers seeking medication assisted treatment (MAT) for opioid use disorder
(OUD). Current literature shows that relationships to children and the process of family
reunification could play large roles in treatment outcomes for these mothers (Comiskey, 2013).
In order to better understand potential motivating factors and the devised approach to OUD
treatment, several components of OUD in mothers must be analyzed. These include different
perceptions of OUD, the effect of OUD on parenting, approaches and barriers to treatment, and
proposed reasons for adherence to treatment.
A Population at Risk
Individuals with history in the criminal legal system are a unique population who are
more likely to face substance use disorders and subsequent overdose than those with no
involvement. Incarcerated mothers with OUD, in particular, are faced with additional challenges
within the criminal justice system, beginning with current legislation. Sentencing legislation such
as mandatory sentencing and three-strikes laws are shown to disproportionately affect
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populations who find difficulty in managing their substance use disorders. These public policy
decisions have been influential in introducing those with the double stigma of mental illness and
substance use, including OUD, into criminal justice populations. In fact, over half the population
of individuals diagnosed with mental illness have also faced substance use problems at some
point in their lives. Unfortunately, this double stigma group is more likely to be homeless upon
release due to lack of social support and correctional oversight. This can further increase chances
for future criminal activity as a survival strategy in the community, while inhibiting the
likelihood of receiving proper treatment and adherence to treatment. Because of these factors,
this dually diagnosed group is also less likely to receive opportunities in rehabilitation programs
and therefore, less likely to recover from substance use disorder. In addition to these
disadvantages, their added time during incarceration leaves them with a triple stigma upon return
to the community (Hartwell, 2004).
Stigmatization
Mothers struggling with OUD may have lost custody of their children for various
reasons. These could include circumstances surrounding living conditions, including poverty, life
stress, or diminished social support. They could also include adverse experiences relating to
OUD, leaving mothers unable to provide the physical and mental needs of their children (Wright
et al., 2018). There are a number of factors that influence reunification of incarcerated mothers
with OUD and their children. Substance use is one of the most common reasons for
stigmatization (Emine, et al., 2018). This stigma can influence those that are making decisions in
the reunification process. Typically, judges take advantage of data provided regarding the
progression of treatment of OUD in order to make a decision about whether reunification will be
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permitted. However, there is a lack of education surrounding the efficacy of medications for
opioid use disorder (MOUD) (Andraka-Christou & Atkins, 2020). In 2016, the National Institute
on Drug Abuse released research publications regarding the value of MOUD as an essential
component of treatment for OUD. The medications that were studied were the U.S. Food and
Drug Administration (FDA)-approved methadone, buprenorphine, and naltrexone (Rogers,
2020). Despite the scientific evidence supporting the effectiveness of MOUD as a treatment
option, only one-third of dependency court staff considers MOUD to be more effective than nonpharmaceutical treatment. This often deters court staff from offering options for reunification for
mothers undergoing MOUD treatment, especially when considering women with children face a
greater stigma than men with children. In addition to this, the negative perception that is held
regarding MOUD could even discourage one from considering this treatment option or decrease
the chance that a defense attorney might recommend it, despite studies showing it is highly
effective (Andraka-Christou & Atkins, 2020).
There is also the consideration of the difference in views held by child protection workers
and parents recovering from OUD, particularly with regards to their concept of recovery. Child
protection workers tend to focus on the chronic and relapsing nature of substance use disorder,
with an emphasis on the negative history of the parents’ illness. As a result, parents often feel
that their capacity for change and improvement are not considered in the decision-making
process (Scott et al., 2018). This conflict adds pressure to the relationship between the agencies
of child protection and parents recovering from OUD and as a result, could ultimately dishearten
treatment efforts from parents who have lost hope in reunification with their children.

3

OUD Influence on Parenting
Aside from difficulties in reobtaining custody of their children, mothers with OUD also
face numerous concerns with respect to parenting and caring for their children in the midst of
treatment. It is often seen that parents who have opioid use disorder struggle in offering a stable
home environment for their children and providing the sensitive care that is often critical in child
development (Wright et al., 2018). One of the most common themes seen in mothers with OUD
is fear. Whether it be fear of losing custody of their child(ren), fear of intervention by child
protective services, or fear of the conditions surrounding their child’s health, parents often face
serious psychosocial repercussions which can affect the well-being of their children (Grant et al.,
2011). In fact, many parents have listed loss of child custody as the most significant negative
consequence of their drug use and therefore their greatest motivator in desire for treatment
(Chatterjee et al., 2018).
Finances can also be a concern with regards to childcare because funds could be
redirected away from childcare costs to pay for opioids or treatment. Additionally, there is the
added factor of financial struggles caused by lack of income as a result of the parents’ drugrelated criminal record. It is important to note, however, that in a 2018 study conducted using
interviews with parents that were staying in family shelters while supporting dependent children,
many parents with OUD felt they were able to provide for their children’s physical needs but
were unable to cater to their emotional needs. Physical needs could include anything from
providing food to ensuring that children get to school, while emotional needs could range from
spending time with children to encouraging reading and other activities which foster growth. The
imbalance between the two can often lead parents to fear the passing on of OUD to their children
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resulting from the limited access to emotional support their children receive from them
(Chatterjee et al., 2018). When women with OUD receive assistance with treatment for OUD,
mental health services, and social support, there is a large increase in life stability and success in
caring for children. These factors typically help balance the various psychosocial factors that
could be responsible for disrupted parenting (Grant et al., 2011).
The stress of parenting plays an influential role in mothers with OUD and how they
address their illness. Parent-related stressors can differ depending on the history and progression
of OUD treatment. The concerns of mothers prior to seeking OUD treatment actually differ from
the concerns they face during treatment. Before the start of OUD treatment, mothers are often
preoccupied with stressors regarding the parental role. This could include anything from child
behavior to co-parenting responsibilities or even child separation. There is also the consideration
of the disconnect between a mother and her child in understanding OUD and how it could affect
parental presence. During OUD treatment, stressors can remain the same or change completely.
New stressors that can arise include court orders for treatment, separation from family, loss of
environmental control, changing mental health concerns, time commitments, or difficulty in
accessing resources (Moreland, et al., 2020). These stressors can all negatively impact treatment
outcomes in mothers as they can lead to relapse of OUD or transform into other dangerous
coping mechanisms. They could even cause harm towards the child, both directly and indirectly.
Treatment Barriers
Mothers struggling with OUD are often inspired to seek out treatment in the hopes that
they will be able to regain custody of their children. However, there are many obstacles that can
arise in obtaining treatment, especially when the mother is already the primary caretaker of her
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children. The primary concerns include childcare, transportation, living conditions, and child
responsibility. One of the main challenges in accessing treatment options is the necessity for
childcare during appointments and visits. If a mother cannot find affordable care for her children
during scheduled treatment times, she may not be able follow through with her appointment.
Another concern is the distance in treatment sites and family shelters, and the lack of available
transportation. This is especially true when the only available public transportation requires
walking long distances, which may not be feasible for families with young children. Even when
a routine is established for transportation, there is no guarantee that housing circumstances will
not change frequently causing the relocation of the family to a new environment. These factors
are all influential in limiting treatment options for parents, even when treatment is desired and
sought out (Chatterjee et al., 2018).
Access to limited resources can play a major role in difficulties surrounding treatment,
but there is also the possibility of difficulties stemmed from the parents’ fear of treatment
consequences. Although evidence has shown that MOUD is extremely effective in managing
OUD, there is the possibility of apprehension towards medication by parents for fear of harming
their children unintentionally. There must be extra care taken on behalf of the parents to ensure
that prescribed medications are not accidentally ingested by children. The possibility of making
this mistake may deter parents from considering certain MOUD options. There is also the added
stigma that arises from many healthcare professionals which causes many patients to feel that
they will never earn the full trust of their care team. This negatively impacts their desire to obtain
treatment because patients often feel defeated and that they will never be able to escape the view
that others hold of them (Chatterjee et al., 2018). Overall, barriers to treatment are significant to
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the course of OUD because they do not merely lead to occasional missed appointments. All the
factors mentioned are possible reasons for discharge from treatment completely. This could
severely negatively impact the outcomes of OUD, thereby influencing family outcomes as well.
Treatment Approaches
Treatment for OUD can be complicated with many elements effecting treatment
outcomes. There is a push among many patients to improve some of the most widespread
methods used today. With the opioid epidemic continuously heightening and relapse rates as
high as 91% (Chopra & Marasa, 2017), there have been many studies centered on reform and the
most beneficial strategies to incorporate for improved OUD treatment outcomes. One of the
common issues seen is the growing rate of reincarceration due to OUD. In order to combat this
cycle, there has been implementation of various programs throughout the country which provide
treatment for OUD in connection with jails. Jails are well equipped to help released inmates
obtain access to overdose-reversing drugs and to improve pain management techniques in
inmates (Fiscella & Gibson, 2018). Research has even shown that starting medication assisted
treatment (MAT) for those being treated for OUD in the criminal justice system reduces rate of
reincarceration. Other benefits include overall decrease of opioid use, decrease in rates of
overdose, and longer commitment to treatments (Rogers, 2020). As a result of these benefits,
program costs have also decreased which is a significant finding considering the estimated $53
billion spent on opioid use disorder every year in the United States (Chopra & Marasa, 2017).
The current systems that are in place in many jails are not beneficial to incarcerated mothers and
do not aid in the progression of OUD treatment. In a sample taken from various jails and prisons
across the United States, nearly one-third mandated that pregnant women undergo drug
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withdrawal despite medical guidelines against this protocol. In addition to this, many women that
were offered MOUD during pregnancy were taken off their medication after delivery (Sufrin et
al., 2020). Such methods exemplify the system that is currently in place which prioritizes the
fetus over the mother, rather than fostering a family-centered approach to treatment.
Following the growing rates of OUD in the United States, many patients have offered
feedback regarding improvements in treatment options and the various flaws that exist in current
methods. One such suggestion is a push towards family-centeredness, including better
communication and respect as well as stronger personal connections between patients and
providers (Short et al., 2021). It is likely that each family will have a different experience with
OUD, and therefore require a unique treatment plan. Personal connections can also be beneficial
in forming a support network which may alleviate the concerns of many mothers who are afraid
to lose child custody over misinterpretation of their behavior (Short et al., 2021). In order to
consider a family’s unique history to devise a treatment plan, there are a number of factors that
should be considered. Some of these include individual mental health issues that often
accompany OUD and the availability of resources including child welfare in particular (Wright
et al., 2018). The consideration of psychosocial conditions can provide insight for the various
stressors that a mother with OUD may be facing and address a potential lack of social support
which can worsen these concerns. Approaching treatment with a more individualized technique
can also help to account for comorbid factors which can complicate care in each case (Chopra &
Marasa, 2017).
One of the most common recommendations is the preference of parents recovering from
OUD to form social networks. This discussion is mainly centered on the network that can be
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formed by parents that are all seeking treatment for OUD. A majority of individuals supported
group treatment in order to have better access and information with regards to parenting
resources. In fact, there was overwhelming support for offering this type of service
simultaneously with other substance use disorder treatment (Moreland et al., 2020). Besides
parenting resources, another advantage of group therapy could be the ability of participants to
relate to one another. Having a personal connection and history with OUD can provide better
insight for understanding the thoughts and experiences of an individual overcoming OUD. As a
result of these considerations, it is important to account for the effect of social connectedness
when devising comprehensive treatment plans for parents seeking positive outcomes.
Motivation for Treatment
Motivation can play a large role in the desire for mothers with OUD to seek out and
remain in treatment. There are a number of considerations that could influence a mother’s
decision, and more research is needed in the field to adapt treatment options to fit these
considerations. The role that children play in a mother’s life have been shown to influence
treatment outcomes, however the overall result is still somewhat controversial. Studies focusing
on this role have varied results. Some have proposed that the removal of children from a
mother’s custody could encourage the mother to seek out more permanent treatment options in
hopes of regaining child custody. On the other hand, it is also possible that limited contact
between mothers and their children could lead to a decrease in treatment participation. A
possible explanation for this could be the substitution of child custody with increased substance
use, in order to cope with the loss and its effects (Chopra & Marasa, 2017).
The case may not be the same, however, when considering the effect that pre-existing
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responsibilities for a child can have in determining treatment outcomes. Having custody of a
child has been shown to motivate mothers to decrease drug use and dependence (Welle-Strand et
al., 2020). Studies even show that women that do not have the responsibility of childcare report
higher rates of drug usage. There are several explanations for why this may be the case. It is
possible that motivation can come from either or both internal and external factors. The inner
desire that a mother may have to provide a better life for their children could been a possible
motivating factor. There is also the possibility that the external factor of fear could cause a
mother to seek treatment. This can especially be seen when considering the fear of child
protective services and the consequences that could result from their interference of the
relationship between a mother and her child (Welle-Strand et al., 2020). Often times, both
internal and external motivations are present at the same time. When this is the case, there is a
much higher success rate for OUD treatment. The coupling of both motivations is especially
prominent and influential when the external motivations can be internalized. Studies show that
stigma can play a significant role in this process. For example, the stigma that comes from many
external sources, such as social pressure, can actually turn from public stigma into internalized
stigma. As a result, the increase in stigma perception could actually lead to increased motivation
in seeking treatment (Emine et al., 2018).
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RESEARCH QUESTION
Reviewing the existing literature leads to many questions regarding the motivations and
factors that influence treatment in incarcerated mothers with OUD. There is limited data in the
effectiveness of MOUD programs affiliated with jails and even less literature on the influence of
small group therapy in such a cohort. This leads to the question: what impacts success among
incarcerated mothers seeking medication assisted treatment for opioid use disorder?
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METHODS
The study relied on interviews with women fitting the study parameters. All participants
had children and were receiving methadone for OUD treatment. The interviews were conducted
via the virtual Orange County Florida Visitation Scheduling platform starting on November 9th,
2021 and concluding on March 7th, 2022. Staff from the Orange County Jail recruited eligible
women and virtual video call visits were scheduled. The interview schedule consisted of twelve
questions (See Appendix A). One question was devoted to experiences with OUD, three
questions were related to perceptions of OUD, two questions focused on motivation for
treatment, four questions were concerned with opinions on treatment and results, and two
questions were dedicated towards parenting and the role of children. All parts of the study were
reviewed and approved by the University of Central Florida Institutional Review Board.
The participants’ responses were based on personal beliefs and experiences. Most of the
participants were engaging and willing to talk about their situation. They seemed to give open
and honest answers to all questions, even if certain topics were difficult for them to address.
Some discussions became emotional, especially those centered around child custody. In all, the
participants appeared to appreciate the opportunity to discuss their stories in hopes to help others
facing similar circumstances.
Sample
The sample consisted of five incarcerated mothers who were undergoing treatment for
OUD. On site employees selected participants that met criteria for interviews. All participants
were provided with informed consent documents prior to agreeing and verbal consent was
obtained prior to the start of the interview.
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Data Collection
Participants were asked the set of twelve interview questions in order and responses were
audio recorded. The audio was transcribed to generate data for qualitative analysis.
Data Analysis
Transcribed data from individual responses were analyzed to identify common themes in
order for responses to be grouped categorically. These categories were further evaluated to
determine any relationships. To honor the confidentiality of all participants in the study, each
participant was given a pseudonym for anonymity.
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RESULTS
The beginning of each interview was similar among almost all the participants. When
asked to share their background experiences with OUD and where those experiences had led
them today, four out of the five women described their first experience with opioids as a legal
prescription they received from their health provider. One participant, Hannah, recounted that
she was prescribed prescription painkillers at the age of fifteen and had been taking opioids from
then on. She went on to point out that in hindsight, she should have never been given the option
to receive opioids as her level of pain was not severe enough to warrant an opioid prescription.
Two of the participants elaborated that they were prescribed opioids due to prior surgeries or
procedures, but growing awareness for the opioid epidemic meant that they were immediately
cut off without being tapered off their medications. They seemed to attribute this messy protocol
to the reason they developed OUD and turned towards illegal drug use. In addition to the
participants’ similarities in the beginning stages of opioid use, four of the five women had also
attempted to get sober multiple times throughout their journeys. They detailed undergoing
multiple cycles of withdrawal, detox, and relapse leading them to where they are today –
receiving methadone for OUD treatment while incarcerated.
Facing Stigma
As shown in previous studies and analyses, most people struggling with OUD agreed that
there is a negative stigma surrounding OUD (Chatterjee et al., 2018). Most of the interviewed
participants recognized this stigma, but also went further to describe how it affects more than just
those with OUD. Hannah elaborated how the stigma surrounding opioid use has made it difficult
for those who need strong painkillers to obtain them stating, “It affects everyone who’s not on it;
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it affects everyone who’s on it”. She spoke about her own mother and the older generation who
are not given the option of certain prescriptions because of the severity of the opioid crisis and
resulting mistrust in the healthcare field.
Another participant, Theresa, focused specifically on the disease aspect of OUD. She felt
that in her experiences, people who had never experienced addiction and withdrawal think of
those with OUD as “weak,” saying “Most people don’t realize that OUD is a sickness that
disturbs your brain - it goes beyond willpower.” She even compared withdrawal symptoms to the
feeling of dying – a feeling that she felt was largely underestimated by those who have never
gone through it. Ruth, a participant who touched on the same ideas as Theresa, took the
discussion further to talk about how her son’s life had been impacted by the stigma she had
faced. She said of other parents, “They don't look at you like you're sick and need help, they look
at you like you’re dangerous or you’re a loser.” Ruth went on to speak of how that negative
stigma affected more than just her, detailing how it had prevented her son from playing with
other children because of their parents’ hesitance and fear.
Some participants described the difficulty in getting rid of the negative stigma that
surrounds them. Isabel spoke of her encounters with law enforcement and Child Protective
Services, where she felt her history of opioid use caused them to believe she was still using drugs
when she was not. She described her long and difficult journey through detoxification and
sobriety which allowed her to be reunified with her children. Shortly after, however, her children
were taken away by Child Protective Services on the basis that she was using drugs, even though
she claimed she was not. Unfortunately, Isabel talked about this experience as the point in which
she felt like she could never win. She relapsed shortly after the incident claiming that there was
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no point in trying to be better if no one would believe her and trust her with her children.
Disordered Parenting
All of the participants noted some type of fear with regards to parenting. As shown in
previous literature, many of these mothers faced serious anxiety and concern over their
children’s well-being because of their shortcomings with parenting (Grant et al., 2011). Most of
the women stated that they tried hiding their drug use from their children but were not able to do
so successfully. Hannah feared that exposing her children to her opioid use would increase the
likelihood that they also develop substance use disorders. She explained that her first child was
born while she was taking heroin and her second was born while she was on methadone, further
causing her to worry about them being exposed to these drugs.
Three out of the five mothers described specific ways in which having OUD hindered
them from their responsibilities as parents. These mainly included being not being available to
their kids, lack of quality time, and difficulty in getting them ready for school or other activities.
Theresa described how her top priority was never being under the influence of opioids in front of
her children, but this was not without drawbacks. Because she chose not to bring opioids in front
of her children, she was physically sick around them as she faced withdrawal symptoms. Another
participant, Mary, talked about how she struggled with getting out of bed to make sure her
daughter got on the school bus on time. As such, many of the participants found difficulty in
managing OUD and parenting, leading to all losing custody of their children. Even in cases
where the children were passed to a family member such as in Isabel’s case, there was hesitancy
in allowing Isabel to regain custody of her children. She explained that it took her a long time to
gain her mother’s trust in being alone with her twins after losing custody of them when they
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were only two years old.
Some of the mothers also faced the concern that their opioid use would set a bad example
for their children. Ruth worried about the decisions she had made while under the influence of
opioids and how those actions could have affected her son. From knocking down entire display
cases in the mall to not being able to stand up in public, she recognized the pain that she had
caused her older stepdaughter and feared the same for her younger son. In reference to hurting
her loved ones she said, “You don’t mean to do it to those around you, but it’s part of the
sickness. I’ve already lost the trust of my stepdaughter, but I’m hoping I caught it early enough
that I don’t lose my son too.” Ruth also talked about fearing the unknown – notably not knowing
how exactly her son would be affected by her and what kinds of resources she would be able to
provide to help him. In all, she was regretful that she could not be the role model she wanted to
be for her son. She implied that she hated feeling like a hypocrite but found inspiration in
changing herself for the sake of her family as she added, “I’ve made my son sick. I’ve made my
son’s father sick. He has contributed so much to my addiction in the name of loving me. I guess I
have to be the first one to say no more.”
Treatment
To assess OUD treatment options available and address any difficulties in accessing
treatment, participants were asked about their personal experiences with treatment along with
any suggestions they felt would have helped them along their journey of recovery. When
discussing treatment availability, four of the five women agreed that it was difficult to find
treatment options and when they did, the only option they found to be available to them was
methadone. Perhaps the most interesting finding was that all the women interviewed mentioned
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that they did not see their treatment with methadone as being the best solution. One of the
reasons for this was that many saw methadone as a short-term treatment. By stating, “It is easy to
get clean, but hard to stay clean,” Hannah implied that the best treatment for OUD lies deeper
than a medication. She spoke of the importance of having someone to keep you accountable and
being connected with one’s own spirituality as a means to end opioid use. Theresa was another
participant who talked about her past experiences leading her down the wrong path. She hoped
that she would have the opportunity to attend therapy, as she felt this would help her deal with
her past and address her current opioid use. Mary also talked about her hesitancy in starting
methadone but feeling like it was the only option available to her at various rehabilitation
centers. She recalled from her own experiences that although methadone allowed her to be
functional and kept her from going back to opioids, it seemed like a replacement rather than a
solution.
A majority of the women agreed that the current systems in place for those with OUD are
not the most beneficial for treatment and recovery. Although Ruth described incarceration as a
“reality check,” she also shared her desire for more help with treatment to be available as she did
not see jail as a long-term solution. In fact, Ruth had described her experience with the Baker
Act process in which she was required to detox for five days before she was released. She wished
then that she would have been provided with more resources to get help with OUD stating, “five
days is not enough to treat an opioid addict.” Even if Ruth had been given better treatment
options, her next concern was being able to afford such treatment without health insurance.
Isabel had a similar view of incarceration, stating that she actually learned how to inject certain
drugs from her time in jail. Any help she received she had to find on her own, but she never felt
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supported or adequately prepared with the proper resources to do so.
Motivation
When asked about the participants’ motivation for seeking out and continuing treatment,
two main responses were prevalent, with four of the five women reporting both. The first being
that a majority of women wanted to seek out treatment in order to provide a better life for their
children. The second overwhelming response was that they wanted to recover for themselves and
become the person they used to be before opioid use.
Besides not going back to jail, Ruth described her reason for continuing treatment as a
way to fulfill certain promises that she made to her son and herself stating, “I have a business,
home, and a car so it [opioid drug use] is just beneath me.” Adding a comment on her
relationship with her son, she recalled her last day before incarceration saying, “I put my hand up
on the truck window as my son was leaving with his father for school and just the look in his
eyes when he looked at my arms that were swollen and scabbed - I just don't want him to look at
me like that anymore.” Theresa also commented on her children by adding that she had seen an
improvement in her relationship with them since starting treatment. Seeing that encouraged her
to want to continue treatment and further reconnect with her children.
Hannah spoke about her children being her greatest motivation for seeking out treatment,
but actually attributed her desire to stay in treatment on her own personal growth – a
differentiation that was unique among the responses. On the other hand, Theresa detailed the
connection between the two aspects. She stated that OUD changed her as a person, which in turn,
changed her relationship with her children and family. Because the two are so closely related,
Theresa’s inspiration was personal but also translated to her relationships with loved ones.
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DISCUSSION
Previous research has shown the impact that the hope of family reunification can have on
mothers seeking treatment for OUD. We have also seen that in cases of child custody, the
majority of dependency court staff does not consider MOUD to be the most effective treatment
option. Considering this, court staff is often not likely to offer child reunification as an option to
mothers undergoing MOUD treatment (Andraka-Christou & Atkins, 2020). However, as stated
by most of the women in the study, methadone treatment was one of the only options available to
them when seeking a treatment plan. Although the hope of regaining child custody is one of the
greatest motivating factors in these women, there must be the understanding that reuniting with
their children is a possibility if they are adhering to treatment and recovering. Providing
educational resources to dependency court staff regarding the efficacy of various treatment
options for OUD may improve the chances of these women reuniting with their children, given
that they are participating in an effective treatment plan. The trust between law enforcement and
parents along with mitigation of certain negative stigmas and false assumptions could help
improve rates of recovery in mothers with OUD.
The desire to seek treatment for OUD is extremely important, but there are many factors
outside of this that could influence success among those who are motivated. Among responses
concerning barriers to treatment, participants mentioned transportation and affordability as issues
they had encountered which made it difficult to commit to treatment once started. These factors
are an opportunity for revising existing policies in order to increase chances of recovery in
individuals with OUD. Another added factor seen previously is the feeling of not being able to
earn the trust of a care team or being able to escape the negative stigma associated with OUD
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(Chatterjee et al., 2018). One of the participants talked about this quite extensively, stating that
not being able to gain the trust of law enforcement and dependency court staff led her to feel
defeated in her journey to recovery and ended up being the contributing factor to her relapse.
When considering the difficulties in parenting caused by OUD, studies highlight the
difference between physical needs and emotional needs. Physical needs of children are often met
more easily especially when parents have other support systems. Emotional needs, on the other
hand, are much more difficult and demanding. The inability to meet their children’s emotional
needs is often the source of worry for many mothers who fear their children will turn to
substance use (Chatterjee et al., 2018). Much of the discussion with participants regarding
parenting were centered around emotional trauma. Rather than just a fear of passing on OUD to
their children, many of the women talked about the strain in relationships they had experienced
as a result of their inability to provide emotional support to their children. This is an important
consideration for motivation to seek treatment because instead of focusing solely on regaining
custody of their children, these mothers were hopeful that they could foster a better relationship
with their children.
In order to consider the various factors that motivated mothers to seek treatment as seen
in the study, there must also be a discussion surrounding personal desire and internal motivation.
As explored by multiple participants, the hope to return to the person they were prior to opioid
use was one of the greatest motivating factors for these women to endure the detoxification
process. However, even though this drive is internal, many of the women mentioned the need to
have someone keeping them accountable throughout the process. One of the ways in which this
could be available to them is through group therapy. As one of the participants described the
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difficulty in withdrawal and detoxification, she added that people who have never experienced
substance use disorders would simply never understand the process and its difficulty. Providing
these women with a group that can support each other and relate to each other would likely be
beneficial for giving them a sense of accountability.
In all, OUD is not straightforward in nature, meaning that its treatment is more
complicated than most current policies imply. OUD can be accompanied by a number of
psychosocial conditions and comorbidities which are not often addressed in treatment options
available to most (Chopra & Marasa, 2017). One of the study participants discussed past trauma
as a potential source of her opioid use disorder and another admitted to struggles with anxiety
and mental health. Although both of these women are likely to have benefited from therapy and
mental health counseling, neither were given the option or resources to do so. These experiences
shine light on the possibility that MOUD alone is not the best solution. Each individual’s history
and journey with OUD is different so repeating the same treatment for everyone is not likely to
be successful. There are a number of treatments that could supplement MOUD which would
focus more on the source of opioid use disorder and its root cause, thereby decreasing overall
relapse rates and increasing chances of treatment adherence.
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LIMITATIONS
Above all other considerations, it is important to note that the sample size for this study
was relatively small at five participants. Although a larger sample was expected, there was
difficulty in obtaining interest for interviews likely due to the nature of the topics discussed and
the vulnerability of the incarcerated population. Additionally, the population of interest itself was
relatively small considering that the study was specifically concerned with incarcerated mothers
with OUD seeking medication assisted treatment. However, given that this study was a
qualitative analysis, there were many in-depth and insightful discussions which highlighted the
appearance of common themes among the participants. These contribute to the existing research
at large and provide a great basis for beneficial changes in policy and further studies to come.
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APPENDIX A
Interview Questions
1. Tell me a little about your experiences with OUD and where these experiences have led
you today.

2. How do you think people perceive OUD?
a. Have you had any experiences in particular which stand out?

3. Do you think there is a stigma surrounding OUD?

4. What made you want to seek out treatment?

5. What do you consider your greatest motivation for staying in treatment?

6. Have you had any difficulties in accessing treatment?

7. Have you found any types of treatment to be more effective than others?
a. Is there anything that you feel would be beneficial to implement in OUD
treatment plans?

8. Have you found treatment to be improving other aspects of your life?
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9. What kinds of obstacles have you had to face when it comes to parenting?

10. What kind of influence has your child(ren) had on your journey with OUD and recovery?
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